MX2025003326A - Suspension esterilizada que contiene un derivado de heterociclideno acetamida - Google Patents

Suspension esterilizada que contiene un derivado de heterociclideno acetamida

Info

Publication number
MX2025003326A
MX2025003326A MX2025003326A MX2025003326A MX2025003326A MX 2025003326 A MX2025003326 A MX 2025003326A MX 2025003326 A MX2025003326 A MX 2025003326A MX 2025003326 A MX2025003326 A MX 2025003326A MX 2025003326 A MX2025003326 A MX 2025003326A
Authority
MX
Mexico
Prior art keywords
acetamide
heterocyclidene
derivative
present disclosure
sterilized
Prior art date
Application number
MX2025003326A
Other languages
English (en)
Spanish (es)
Inventor
Yuki Yamashita
Original Assignee
Senju Pharma Co
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Mochida Pharm Co Ltd filed Critical Senju Pharma Co
Publication of MX2025003326A publication Critical patent/MX2025003326A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2025003326A 2022-09-29 2025-03-20 Suspension esterilizada que contiene un derivado de heterociclideno acetamida MX2025003326A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022156060 2022-09-29
PCT/JP2023/035547 WO2024071348A1 (ja) 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (1)

Publication Number Publication Date
MX2025003326A true MX2025003326A (es) 2025-05-02

Family

ID=90478164

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025003326A MX2025003326A (es) 2022-09-29 2025-03-20 Suspension esterilizada que contiene un derivado de heterociclideno acetamida

Country Status (7)

Country Link
EP (1) EP4595959A1 (cg-RX-API-DMAC7.html)
JP (2) JP7589393B2 (cg-RX-API-DMAC7.html)
KR (1) KR20250065723A (cg-RX-API-DMAC7.html)
CN (1) CN119997937A (cg-RX-API-DMAC7.html)
AU (1) AU2023352012A1 (cg-RX-API-DMAC7.html)
MX (1) MX2025003326A (cg-RX-API-DMAC7.html)
WO (1) WO2024071348A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025206172A1 (ja) * 2024-03-28 2025-10-02 千寿製薬株式会社 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754566B2 (ja) 2005-07-22 2011-08-24 持田製薬株式会社 新規なヘテロシクリデンアセトアミド誘導体
JP6230743B1 (ja) 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
BR112022005992A2 (pt) 2019-10-04 2022-06-21 Mochida Pharm Co Ltd Fármaco contendo derivado de heterociclideno acetamida
JP7663009B2 (ja) 2021-03-31 2025-04-16 ニデックパワートレインシステムズ株式会社 回転電機、およびポンプ

Also Published As

Publication number Publication date
JPWO2024071348A1 (cg-RX-API-DMAC7.html) 2024-04-04
CN119997937A (zh) 2025-05-13
EP4595959A1 (en) 2025-08-06
JP2025024083A (ja) 2025-02-19
JP7589393B2 (ja) 2024-11-25
AU2023352012A1 (en) 2025-04-03
KR20250065723A (ko) 2025-05-13
WO2024071348A1 (ja) 2024-04-04

Similar Documents

Publication Publication Date Title
MX2022013647A (es) Imidazopiridazinas como moduladores de il-17.
MX2025008327A (es) Composiciones y metodos para el tratamiento de trastornos del snc
ES2052784T3 (es) Procedimiento para la produccion de una composicion terapeutica administrable localmente para una enfermedad inflamatoria.
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
ZA202212095B (en) Il4i1 inhibitors and methods of use
PH12021553202A1 (en) Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide
MX2019013562A (es) Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.
MX2024003770A (es) Compuestos de imidazopiridazina inhibidores de il-17.
MX2022011565A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12021551412A1 (en) Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
MX2025005474A (es) Farmaco farmaceutico que contiene derivado de heterocicliden acetamida
MX2024005063A (es) Inhibidores de espirotriciclo de ripk1 y metodos de uso de los mismos.
SE0002729D0 (sv) Novel compound form
TN2023000279A1 (en) Oral solution based on citicoline and nicotinamide for use in the treatment of glaucoma
MX2023011649A (es) Suspension que contiene derivado de heterociclidenacetamida.
JP2003128552A (ja) 粘膜適用組成物
MX2023003245A (es) Derivados de amina novedosos.
MX2025008207A (es) Estereoisomero y derivado deuterado de compuesto de pirazoloquinazolina y uso
MX2025008101A (es) Compuestos moduladores de receptores de dopamina d3/d2
BRPI0412131A (pt) métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnico
MX2025003934A (es) Métodos para preparar derivados de carbamato
PL431139A1 (pl) Kompozycja farmaceutyczna bimatoprostu i tymololu
JP2013234176A (ja) カスポファンギンまたはその塩、およびビグアニド系化合物またはその塩を含有する抗原虫組成物
PH12020551194A1 (en) Eye drops in form of solution comprising benzopyran derivative or pharmaceutically acceptable salt thereof
JP5650397B2 (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物